30Sep/13

Glenmark gains 2% on USFDA nod for Hydrocortisone Butyrate – Moneycontrol.com


Economic Times

Glenmark gains 2% on USFDA nod for Hydrocortisone Butyrate
Moneycontrol.com
Shares of Glenmark Pharmaceuticals gained more than 2 percent in late morning trade Monday as the pharmaceutical company received USFDA’s nod for its Hydrocortisone Butyrate Cream USP, 0.1 percent – a generic version of Locoid Lipocream.
Glenmark Generics gets US FDA nod for hydrocortisone butyrate creampharmabiz.com
Glenmark gets another approval by USFDA: Nod for generic Hydrocortisone Daily Bhaskar
Glenmark Generics Receives Approval For Hydrocortisone Butyrate Cream USP RTT News
Business Standard –Hindu Business Line
all 6 news articles »